<DOC>
	<DOC>NCT00096798</DOC>
	<brief_summary>The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid (ethyl-EPA), an omega-3 fatty acid, in treating depression.</brief_summary>
	<brief_title>Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression</brief_title>
	<detailed_description>Evidence suggests that omega-3 fatty acids may help reduce symptoms of depression. This study will determine whether ethyl-EPA, an omega-3 fatty acid, can be used safely and effectively to treat major depression. Participants will be randomly assigned to receive either ethyl EPA-containing pills or placebo daily for 8 weeks. Each week, participants will be asked to complete questionnaires which will be used to assess the severity of their depression.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Major depressive disorder Serious comorbid psychiatric disorder Unstable medical illness Prior use of any omega3 fatty acid product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Fatty Acids, Omega-3</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Eicosapentanoic Acid</keyword>
</DOC>